Factor | Quintana.Hayashi_2012_AppandEnvMic (10322)

10.1128/AEM.07723-11

Production Type

Swine | Carcass

8

Description

Predominantly C. coli (98.3%).

Resistance Outcomes

Resistance Microbe Outcome
Tetracycline
/
Campylobacter coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic Free 49.40 156
Conventional 82.90 158
Ciprofloxacin
/
Campylobacter coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic Free 0.00 156
Conventional 15.20 158
Erythromycin
/
Campylobacter coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic Free 34.00 156
Conventional 20.90 158
Nalidixic Acid
/
Campylobacter coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic Free 0.00 156
Conventional 15.20 158
Telithromycin
/
Campylobacter coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic Free 26.30 156
Conventional 7.00 158
Gentamicin
/
Campylobacter coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic Free 0.00 156
Conventional 0.00 158
Florfenicol
/
Campylobacter coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic Free 0.00 156
Conventional 0.00 158
Clindamycin
/
Campylobacter coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic Free 10.30 156
Conventional 0.60 158